 |
 |
|
|
|
| Regorafenib|1019206-88-2 |
 |
| 99% |
 |
| 1019206-88-2 |
 |
Indications: for the treatment of adult epilepsy patients with partial seizures
|
 |
English chemical name:
4-[4-({[4-chloro-3-(trifluoromethyl) phenyl] carbamoyl}
amino)-3-fluorophenoxy]-N-methylpyridine-2-
carboxamide monohydrate
CAS NO.:1019206-88-2
Appearance:pink to light brown solid powder
Purity(HPLC):>=99.5%
Assay(HPLC):98%-102%
|
| Industrial field |
pharmaceutical |
|
|
 |
|
|
|
|
|
 |
| There are no existing companies to distribute selected chemical product |
|
 |
|
|
|
